Google has updated its iconic 'G' logo for the first time in almost a decade. While the new logo retains the 'G' in the familiar Product Sans format, it introduces significant changes to the ...

BERLIN, May 05, 2025--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment ...

Multibagger stock: Pharma company Sudarshan Pharma Industries share price will remain in focus in Monday's trading session after the company reported its half yearly and FY25 financial ...

Essa Pharma Inc. + Watchlist Alert EPIX US Open Last Updated: Jun 2, 2025 9:50 a.m. EDT Real time quote $ 1.6750-0.0050-0.30% Previous Close $1.6800 Toggle Chart Options Advanced Charting Range ...

Innocan's first fully-granted patent in Mexico Covers Innocan's proprietary cannabis-based pain relief topical Indication of Innocan's growing intellectual property portfolio This patent covers a ...

Pharma stocks defy market trend: Dr Reddy’s, Aurobindo, Granules among top gainers as investors turn to defensive bets amid global developments (Image: Canva) Pharma stocks are bucking the ...

The updated "G" logo has a gradient effect now, which could be an attempt to better sync design with the company's AI products. Imad is a senior reporter covering Google and internet culture.

Google’s logo just got a little bit blurrier. In a new logo quietly rolled out across iOS and Pixel, the search giant ditches its color-blocked “G” for gradients. Google’s new logo keeps ...

After almost a decade, Google has revealed a major overhaul of its recognizable "G" logo, the first important visual redesign since the flat, color-blocked look was implemented in 2015.

Another Big Pharma is opening up its wallet to pour billions into its U.S. operations amid political pressure from the Trump administration. This time it’s Gilead coming to the table with a ...

"We are excited to enter the next phase of Ousia Pharma's journey, advancing our groundbreaking platform towards clinical development," said Anders B. Klein, PhD, CEO of Ousia Pharma. "The strong ...